Association between blood lipid levels and the risk of liver cancer: a systematic review and meta-analysis
- PMID: 38376693
- PMCID: PMC11129988
- DOI: 10.1007/s10552-024-01853-9
Association between blood lipid levels and the risk of liver cancer: a systematic review and meta-analysis
Abstract
Purpose: The association between blood lipid levels and the risk of developing liver cancer remains a subject of ongoing debate. To elucidate this association, we conducted a meta-analysis by systematically incorporating data from all relevant prospective cohort studies.
Methods: We conducted a systematic search of the PubMed, Embase, Web of Science, and Cochrane Library databases covering studies published from database inception through July 2023. This study included prospective cohort studies related to lipid profiles (e.g., total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels) that reported hazard ratios (HRs) or relative risks (RRs) with corresponding 95% confidence intervals (95% CIs) to investigate their association with the risk of liver cancer. During the analysis process, we used fixed-effects or random-effects models based on the level of heterogeneity among the studies and obtained pooled risk ratios using these models. To ensure the robustness and reliability of the study findings, we also conducted sensitivity analyses and publication bias analyses.
Results: After conducting a systematic search, 12 studies were identified from a total of 11,904 articles and were included in the meta-analysis. These studies included a combined population of 10,765,221 participants, among whom 31,055 cases of liver cancer were reported. The analysis revealed that the pooled HR for the serum TC concentration (highest versus lowest) was 0.45 (95% CI = 0.35-0.58, I2 = 78%). For TGs, the HR was 0.67 (95% CI = 0.46-0.96, I2 = 86%), while for HDL-C, the HR was 0.72 (95% CI = 0.58-0.90, I2 = 65%). The HR for LDL-C was 0.51 (95% CI = 0.23-1.13, I2 = 93%).
Conclusion: The findings of this study indicate that serum TC, TG, and HDL-C levels are negatively associated with liver cancer risk, suggesting that higher concentrations of these lipids are associated with a reduced risk of liver cancer. However, no significant association has been found between LDL-C levels and liver cancer risk.
Keywords: Blood lipids; Cohort study; Liver neoplasms; Meta-analysis.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Association between blood lipid levels and risk of gastric cancer: A systematic review and meta-analysis.PLoS One. 2023 Jul 7;18(7):e0288111. doi: 10.1371/journal.pone.0288111. eCollection 2023. PLoS One. 2023. PMID: 37418353 Free PMC article.
-
A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy.Sci Rep. 2021 Jan 12;11(1):499. doi: 10.1038/s41598-020-79276-0. Sci Rep. 2021. PMID: 33436718 Free PMC article.
-
Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.J Clin Lipidol. 2020 Jan-Feb;14(1):133-142.e3. doi: 10.1016/j.jacl.2019.12.002. Epub 2019 Dec 20. J Clin Lipidol. 2020. PMID: 31926850
-
Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies.PLoS One. 2015 Nov 10;10(11):e0142669. doi: 10.1371/journal.pone.0142669. eCollection 2015. PLoS One. 2015. PMID: 26554382 Free PMC article.
-
Systematic review and meta-analysis of randomized controlled trials on the effects of obeticholic acid on the blood lipid profile: Insights into liver disorders and liver cancer.Eur J Pharmacol. 2020 Dec 15;889:173616. doi: 10.1016/j.ejphar.2020.173616. Epub 2020 Oct 6. Eur J Pharmacol. 2020. PMID: 33035521
Cited by
-
Statin use and risk of HCC in patients with MASLD and T2DM: an umbrella review and meta-analysis.BMC Cancer. 2025 May 14;25(1):875. doi: 10.1186/s12885-025-14299-2. BMC Cancer. 2025. PMID: 40369443 Free PMC article.
-
Lipid Levels and Lung Cancer Risk: Findings from the Taiwan National Data Systems from 2012 to 2018.J Epidemiol Glob Health. 2025 Jan 30;15(1):11. doi: 10.1007/s44197-025-00351-8. J Epidemiol Glob Health. 2025. PMID: 39883280 Free PMC article.
-
Assessing the influence of metabolic syndrome on thyroid cancer: insights from a Mendelian randomization approach.Discov Oncol. 2025 Jun 10;16(1):1048. doi: 10.1007/s12672-025-02760-4. Discov Oncol. 2025. PMID: 40494944 Free PMC article.
References
-
- Shi TT, Liu ZQ, Fan H, Zhang PY, Yu SZ, Zhang TJ. [Analysis on incidence trend of liver cancer in China, 2005–2016] Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43:330–335. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous